HCWB — Hcw Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- $57.87m
- $60.58m
- $2.84m
Annual cashflow statement for Hcw Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.29 | -5.8 | -12.9 | -14.9 | -25 |
| Depreciation | |||||
| Non-Cash Items | 0.002 | 0.022 | -0.112 | 1.31 | 5.99 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.104 | -5.25 | 1.46 | 2.49 | -4.64 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.77 | -10.4 | -11 | -10.4 | -22.5 |
| Capital Expenditures | -1.46 | -0.187 | -0.047 | -10.3 | -6.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | -35 | 25 | 10 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.46 | -0.187 | -35 | 14.7 | 3.8 |
| Financing Cash Flow Items | — | — | -6.76 | -0.191 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.4 | 11.7 | 49.3 | 6.27 | -0.015 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.22 | 1.1 | 3.27 | 10.6 | -18.7 |